Comoglu Mustafa, Acehan Fatih, Sahiner Enes Seyda, Camli Huseyin, Kilic Zeki Mesut Yalin, Odemis Bulent, Ates Ihsan
Department of Internal Medicine, Ankara Bilkent City Hospital, Ankara, Turkiye.
Department of Gastroenterology, Ankara Bilkent City Hospital, Ankara, Turkiye.
J Hepatobiliary Pancreat Sci. 2025 Aug;32(8):591-601. doi: 10.1002/jhbp.12164. Epub 2025 Jun 5.
BACKGROUND/PURPOSE: Current guidelines do not provide specific recommendations regarding the timing of endoscopic retrograde cholangiopancreatography (ERCP) in patients with acute cholangitis (AC) concurrent with acute gallstone pancreatitis (AGP). This study evaluated the impact of ERCP timing on clinical outcomes.
A total of 144 patients diagnosed with AC concurrent with AGP between March 2019 and February 2024 were included in the study. Patients were classified into two groups: urgent ERCP group (ERCP ≤ 24 h) and non-urgent ERCP group (ERCP 24-72 h). Clinical outcomes were compared using propensity score matching (PSM) analysis.
After PSM, two well-balanced groups of 55 patients were created. The median ERCP time was 18 (13-21) hours in the urgent group and 41 (36-54) hours in the non-urgent group. There was no significant difference in composite outcomes, including in-hospital mortality, prolonged hospital stay, severe pancreatitis, or late localized/systemic complications of pancreatitis [11 (20%) vs. 16 (29.1%); p = 0.268]. Additionally, no significant difference was observed between the groups regarding prolonged hospital stay (p = 0.506), ICU admission (p = 0.680), or in-hospital mortality (p = 0.161).
Urgent ERCP within 24 h does not significantly improve clinical outcomes compared to ERCP performed within 24-72 h in patients with AC and AGP.
背景/目的:目前的指南未就急性胆管炎(AC)合并急性胆石性胰腺炎(AGP)患者进行内镜逆行胰胆管造影(ERCP)的时机提供具体建议。本研究评估了ERCP时机对临床结局的影响。
本研究纳入了2019年3月至2024年2月期间诊断为AC合并AGP的144例患者。患者分为两组:急诊ERCP组(ERCP≤24小时)和非急诊ERCP组(ERCP 24 - 72小时)。采用倾向评分匹配(PSM)分析比较临床结局。
PSM后,创建了两组各55例平衡良好的患者。急诊组的ERCP中位时间为18(13 - 21)小时,非急诊组为41(36 - 54)小时。包括住院死亡率、住院时间延长、重症胰腺炎或胰腺炎晚期局部/全身并发症在内的综合结局无显著差异[11例(20%) vs. 16例(29.1%);p = 0.268]。此外,两组在住院时间延长(p = 0.506)、入住重症监护病房(p = 0.680)或住院死亡率(p = 0.161)方面也无显著差异。
对于AC合并AGP患者,与24 - 72小时内进行的ERCP相比,24小时内进行急诊ERCP并不能显著改善临床结局。